These data demonstrate that elevated IL-36γ levels are associated with lower blood glucose levels among obese patients with diabetes and indicate that IL-36 cytokines may act to promote metabolic health in obesity. The gene discussed is IL36G; the disease is obesity due to melanocortin 4 receptor deficiency.